Variability in the pharmacokinetics of epirubicin: a population analysis
- 1 January 1992
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 29 (5), 391-395
- https://doi.org/10.1007/bf00686009
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- PHARMACOKINETICS AND TOXICITY OF 2 SCHEDULES OF HIGH-DOSE EPIRUBICIN1990
- Clinical Pharmacokinetics-Pharmacodynamicsof Anticancer DrugsClinical Pharmacokinetics, 1989
- Pharmacokinetics of AnthracyclinesActa Oncologica, 1989
- Relationship between systemic 5-FU passage and response in colorectal cancer patients treated with intrahepatic chemotherapyCancer Chemotherapy and Pharmacology, 1987
- Clinical Pharmacodynamics of High-Dose Methotrexate in Acute Lymphocytic LeukemiaNew England Journal of Medicine, 1986
- Pharmacokinetics and metabolism of epirubicin during repetitive courses of administration in Hodgkin's patientsEuropean Journal of Cancer and Clinical Oncology, 1985
- Anticancer drug pharmacodynamicsCancer Chemotherapy and Pharmacology, 1985
- Effect of cyclophosphamide pretreatment on the short-term disposition and biliary excretion of adriamycin metabolites in ratCancer Chemotherapy and Pharmacology, 1982
- Extraction of Anthracyclines from Biological Fluids for HPLC EvaluationJournal of Liquid Chromatography, 1980
- Liquid Chromatographic Analysis of Adriamycin and Metabolites in Biological FluidsJournal of Liquid Chromatography, 1978